MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

19 May 2025 Evaluate
The sales moved down -34.55% to Rs. 244.32 millions for the March 2025 quarter as compared to Rs. 373.32 millions during the corresponding quarter last year.Profit after Tax for the quarter ended March 2025 saw a decline of -47.61% from Rs. 125.93 millions to Rs. 65.97  millions.The company reported a degrowth in operating Profit to 121.63 millions from 182.55 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 244.32 373.32 -34.55 1085.96 1258.95 -13.74 1085.96 1258.95 -13.74
Other Income 22.87 13.24 72.73 37.30 30.71 21.46 37.30 30.71 21.46
PBIDT 121.63 182.55 -33.37 429.42 448.77 -4.31 429.42 448.77 -4.31
Interest 9.58 1.46 556.16 20.77 5.98 247.32 20.77 5.98 247.32
PBDT 112.05 181.09 -38.12 408.65 442.79 -7.71 408.65 442.79 -7.71
Depreciation 24.24 18.57 30.53 95.67 61.10 56.58 95.67 61.10 56.58
PBT 87.81 162.52 -45.97 312.98 381.69 -18.00 312.98 381.69 -18.00
TAX 21.84 36.59 -40.31 81.99 100.52 -18.43 81.99 100.52 -18.43
Deferred Tax -0.81 -0.15 440.00 -0.45 6.74 -106.68 -0.45 6.74 -106.68
PAT 65.97 125.93 -47.61 230.99 281.17 -17.85 230.99 281.17 -17.85
Equity 128.38 125.83 2.03 128.38 125.83 2.03 128.38 125.83 2.03
PBIDTM(%) 49.78 48.90 1.81 39.54 35.65 10.93 39.54 35.65 10.93
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..